Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar 29;114(7):716-22.
doi: 10.1038/bjc.2016.37. Epub 2016 Feb 23.

From obesity to diabetes and cancer: epidemiological links and role of therapies

Affiliations
Review

From obesity to diabetes and cancer: epidemiological links and role of therapies

Custodia García-Jiménez et al. Br J Cancer. .

Abstract

Increasing evidence suggests a complex relationship between obesity, diabetes and cancer. Here we review the evidence for the association between obesity and diabetes and a wide range of cancer types. In many cases the evidence for a positive association is strong, but for other cancer types a more complex picture emerges with some site-specific cancers associated with obesity but not to diabetes, and some associated with type I but not type II diabetes. The evidence therefore suggests the existence of cumulative common and differential mechanisms influencing the relationship between these diseases. Importantly, we highlight the influence of antidiabetics on cancer and antineoplastic agents on diabetes and in particular that antineoplastic targeting of insulin/IGF-1 signalling induces hyperglycaemia that often evolves to overt diabetes. Overall, a coincidence of diabetes and cancer worsens outcome and increases mortality. Future epidemiology should consider dose and time of exposure to both disease and treatment, and should classify cancers by their molecular signatures. Well-controlled studies on the development of diabetes upon cancer treatment are necessary and should identify the underlying mechanisms responsible for these reciprocal interactions. Given the global epidemic of diabetes, preventing both cancer occurrence in diabetics and the onset of diabetes in cancer patients will translate into a substantial socioeconomic benefit.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Association of cancers (classified by site) with obesity, diabetes and treatments. Raw data for this figure are presented in Supplementary Tables S1 and S2. Cancer relative risk was directly – red colours – or inversely (protection) – green colours – associated with obesity (Ob), TIID, TID or ADTs: insulin (Ins) and sulphonylurea (SU) that increase circulating insulin and metformin (Met) and TZDs that decrease blood glucose. Not statistically significant (NS) association (blue squares). Squares with very light red or green shadow represent trends to direct (red shadow) or inverse (green shadow) association, although statistically not significant mainly because of lack of sufficient studies.

References

    1. Adams TD, Stroup AM, Gress RE, Adams KF, Calle EE, Smith SC, Halverson RC, Simper SC, Hopkins PN, Hunt SC (2009) Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring) 17(4): 796–802. - PMC - PubMed
    1. Argiles JM, Busquets S, Stemmler B, Lopez-Soriano FJ (2014) Cancer cachexia: understanding the molecular basis. Nat Rev Cancer 14(11): 754–762. - PubMed
    1. Baur DM, Klotsche J, Hamnvik OP, Sievers C, Pieper L, Wittchen HU, Stalla GK, Schmid RM, Kales SN, Mantzoros CS (2011) Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort. Metabolism 60(10): 1363–1371. - PubMed
    1. Bosetti C, Rosato V, Buniato D, Zambon A, La Vecchia C, Corrao G (2013) Cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis. Oncologist 18(2): 148–156. - PMC - PubMed
    1. Chang CH, Lin JW, Wu LC, Lai MS, Chuang LM (2012) Oral insulin secretagogues, insulin, and cancer risk in type 2 diabetes mellitus. J Clin Endocrinol Metab 97(7): E1170–E1175. - PubMed

Publication types

MeSH terms

Substances